HPVCARE 14 vaginal suppositories
HPVCARE 14 vaginal suppositories
Available in stock
In all cases where surgical treatment is not necessary and the status of HPV infection and lesions induced by it should simply be monitored (wait and see recommendation):
1. In case of a positive HPV test, to promote the elimination of the virus.
2. Following a positive cytological diagnosis (Pap smear) to promote the elimination of the virus and prevent HPV-induced carcinogenesis.
4. In cases of low-grade neoplasia (CIN1), to promote regression of the histological diagnosis and to prevent progression to cervical cancer.
5. After surgical treatment of high-grade neoplasia (CIN2-CIN3) to promote the return of normal tissue and prevent relapse.
6. When HPV infection is not present (secondary placement!)
7. In cases of inflammation affecting the cervical/vaginal epithelium, which may lead to cytological changes in epithelial cells (e.g., ASC-US with negative HPV test, ectropion, metaphlogistic lesions)
8. In cases of extensive transformation zones in immature metaplasia to prevent HPV integration.
Couldn't load pickup availability
Benefits
Benefits
Usage tips
Usage tips
Dosage: It is recommended to take 1 ovule per day for 14 days, starting on the last day of menstruation. Do not exceed the recommended dose. Repeat for 3 consecutive months INSTRUCTIONS FOR USE: Insert one vaginal suppository deep into the vagina at night before bed, while lying on your back.
Composition
Composition
Precautions
Precautions
Additional note
Additional note
Cantabria Labs Portugal Endereço: Azinhaga da Torre do Fato 19B 1º Esqº, 1600-299 Lisboa Telefone: 21 099 7092



